1. Home
  2. PYPD vs PUSA Comparison

PYPD vs PUSA Comparison

Compare PYPD & PUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$6.51

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Logo Aureus Greenway Holdings Inc. Common Stock

PUSA

Aureus Greenway Holdings Inc. Common Stock

N/A

Current Price

$1.12

Market Cap

101.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
PYPD
PUSA
Founded
2008
2023
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
107.0M
101.2M
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
PYPD
PUSA
Price
$6.51
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
★ $11.50
$6.25
AVG Volume (30 Days)
193.8K
★ 727.8K
Earning Date
11-11-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,964,377.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$301.76
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.50
$1.27
52 Week High
$7.15
$4.45

Technical Indicators

Market Signals
Indicator
PYPD
PUSA
Relative Strength Index (RSI) 66.10 26.75
Support Level $4.26 N/A
Resistance Level $7.15 $4.05
Average True Range (ATR) 0.52 0.19
MACD 0.05 0.02
Stochastic Oscillator 62.63 5.88

Price Performance

Historical Comparison
PYPD
PUSA

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About PUSA Aureus Greenway Holdings Inc. Common Stock

Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.

Share on Social Networks: